Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
What they do:
Unlocking the power of biotech with modern software for modern science
Quick facts:
HQ: San Francisco, CA, United States
What they do:
We make robots for biologists.
Quick facts:
HQ: New York, NY, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
AI drug discovery platform for neurotherapeutics
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$2.16M · Options · Feb 2026
What they do:
Next-generation DNA synthesis using enzymes
Quick facts:
HQ: San Francisco, CA, United States
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Irvine, CA, United States
3 employees, according to the company profile.
There are no funding rounds for Entelexo Biotherapeutics in our data.
Similar startups: Benchling, Opentrons, and Numerion Labs.